Status: Recruiting
BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation
Prospective, 2-arm, randomised (2:1), multicentre, open-label clinical trial in patients with severe emphysema. The intervention arm will be treated with Bronchoscopic lung volume reduction in severe emphysema using thermoablation.The interventional treatment (bronchoscopic lung volume reduction) is compared with the usual conservative standard therapy (GOLD guidelines).
Participants needed: 224
Trial details
Age: 40-75Biological sex: AllType: InterventionalSponsor: IHF GmbH - Institut für HerzinfarktforschungUpdated: Aug 24, 2025Locations: 12
Eligibility criteria
Age: ≥ 40 years and ≤ 75 years [+19]
Any condition that would interfere with the conduct of the clinical trial follow... [+25]